Mablink Bioscience
FranceWho owns Mablink Bioscience?
Mablink Bioscience was owned by Lazard Elaia Capital through Elaia Legacy Fund (2002 vintage) from 2021 to 2024, exited via Trade Sale. Across its history, Mablink Bioscience has been through 5 private equity ownership periods, detailed in the timeline below.
Buyer identity available on Pro.
Hand-verified · updated 2026-04-21
Key facts
- ·Fully exited in 2024.
- ·Average hold across 5 realized cycles: 2 years.
- ·5 distinct PE sponsors across ownership cycles.
Ownership history
5 ownership periods · co-invest detected
More from Elaia Legacy Fund
Other portfolio companies in the same fund.
UKMore PE-backed in Biotech
Comparable biotech deals from other GPs.
USSave this record to your watchlist and pick up your research where you left off. No spam.
Who could buy Mablink Bioscience?
5 strategic and 115financial buyers match this company's sector and geography profile, ranked from verified European deal history.
Find likely buyersGet the full record on Mablink Bioscience.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in